X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22060) 22060
Book Review (3486) 3486
Publication (1307) 1307
Conference Proceeding (231) 231
Book Chapter (212) 212
Dissertation (82) 82
Magazine Article (57) 57
Newsletter (54) 54
Web Resource (32) 32
Book / eBook (24) 24
Paper (9) 9
Reference (9) 9
Data Set (6) 6
Trade Publication Article (4) 4
Newspaper Article (3) 3
Streaming Video (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14946) 14946
humans (13636) 13636
dyslipidemia (12280) 12280
male (9296) 9296
female (8497) 8497
risk factors (7036) 7036
middle aged (6541) 6541
adult (5178) 5178
cholesterol (4477) 4477
aged (4343) 4343
obesity (3781) 3781
hypertension (3462) 3462
metabolic syndrome (3436) 3436
lipids (3293) 3293
dyslipidemias - drug therapy (3247) 3247
diabetes (3136) 3136
dyslipidemias - blood (2889) 2889
prevalence (2765) 2765
atherosclerosis (2756) 2756
dyslipidemias - epidemiology (2683) 2683
animals (2660) 2660
insulin resistance (2657) 2657
cardiovascular disease (2578) 2578
dyslipidemias - complications (2517) 2517
diabetes mellitus (2326) 2326
cardiovascular diseases (2278) 2278
dyslipidemias (2255) 2255
endocrinology & metabolism (2172) 2172
risk (2160) 2160
cardiac & cardiovascular systems (2148) 2148
cardiovascular-disease (2132) 2132
lipids - blood (2081) 2081
insulin-resistance (2073) 2073
research (2058) 2058
body mass index (2044) 2044
triglycerides - blood (2044) 2044
coronary-heart-disease (2013) 2013
cholesterol, ldl - blood (1899) 1899
triglycerides (1861) 1861
statins (1794) 1794
pharmacology & pharmacy (1782) 1782
cholesterol, hdl - blood (1720) 1720
cross-sectional studies (1702) 1702
lipoproteins (1693) 1693
disease (1682) 1682
health aspects (1654) 1654
adolescent (1632) 1632
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1606) 1606
treatment outcome (1548) 1548
medicine, general & internal (1525) 1525
peripheral vascular disease (1509) 1509
mortality (1506) 1506
metabolism (1464) 1464
risk-factors (1451) 1451
inflammation (1427) 1427
analysis (1413) 1413
care and treatment (1399) 1399
hypolipidemic agents - therapeutic use (1362) 1362
cholesterol - blood (1358) 1358
blood pressure (1352) 1352
cardiovascular diseases - prevention & control (1341) 1341
glucose (1327) 1327
prevention (1325) 1325
biomarkers - blood (1304) 1304
type 2 diabetes (1301) 1301
young adult (1288) 1288
hypertension - epidemiology (1285) 1285
cardiovascular diseases - etiology (1270) 1270
low density lipoproteins (1244) 1244
nutrition & dietetics (1202) 1202
insulin (1199) 1199
mice (1198) 1198
abridged index medicus (1183) 1183
biochemistry & molecular biology (1180) 1180
medicine (1157) 1157
dyslipidemias - metabolism (1152) 1152
diet (1144) 1144
cardiovascular (1116) 1116
cardiovascular diseases - epidemiology (1114) 1114
association (1106) 1106
oxidative stress (1104) 1104
physiological aspects (1099) 1099
aged, 80 and over (1091) 1091
dyslipidemias - etiology (1062) 1062
child (1031) 1031
hypercholesterolemia (1024) 1024
rats (1020) 1020
dyslipidemias - diagnosis (1013) 1013
density-lipoprotein cholesterol (1005) 1005
risk assessment (1005) 1005
cardiovascular risk (995) 995
retrospective studies (995) 995
comorbidity (979) 979
population (963) 963
myocardial-infarction (934) 934
liver (928) 928
studies (925) 925
research article (904) 904
metabolic disorders (894) 894
lipid metabolism (887) 887
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (16) 16
Gerstein Science - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Scarborough Hospital - Online (2) 2
Mt Sinai Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19882) 19882
Spanish (725) 725
Portuguese (376) 376
Russian (284) 284
French (271) 271
Chinese (207) 207
Japanese (156) 156
German (144) 144
Czech (121) 121
Polish (96) 96
Korean (83) 83
Italian (58) 58
Hungarian (32) 32
Turkish (28) 28
Romanian (18) 18
Croatian (17) 17
Slovak (14) 14
Ukrainian (13) 13
Persian (12) 12
Lithuanian (9) 9
Swedish (6) 6
Danish (4) 4
Finnish (4) 4
Slovenian (4) 4
Serbian (3) 3
Dutch (2) 2
Hebrew (2) 2
Icelandic (2) 2
Indonesian (2) 2
Arabic (1) 1
Belarusian (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Greek (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Web Resource
THE EFFECTS OF MENOPAUSE ON THE SERUM LIPID PROFILE OF NORMAL FEMALES OF SOUTH EAST NIGERIA, 12/2005
Dyslipidemia in menopause is a known feature in women, whether it leads to significant increase in the development of coronary heart disease (CHD) is still... 
Menopause, Dyslipidemia, Cholesterol
Journal
2019, ISBN 9781496347442
"Dyslipidemia: A Clinical Approach is intended as a low-cost, quick-reference, easy-to-navigate guide for a broad range of healthcare professionals that will... 
Dyslipidemias | therapy | diagnosis
Web Resource
Journal Article
JAMA, ISSN 0098-7484, 11/2016, Volume 316, Issue 19, pp. 1997 - 2007
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 246, pp. 243 - 250
Abstract Objective Since dyslipidaemia is one of the most important risk factors for coronary heart disease (CHD), lowering of LDL-cholesterol (LDL-C) causes... 
Cardiovascular | LDL-Cholesterol | EUROASPIRE | Secondary prevention | Non-HDL-Cholesterol | Coronary heart disease | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | LDL CHOLESTEROL | PERCEPTION | DENSITY-LIPOPROTEIN CHOLESTEROL | STATIN THERAPY | PREDICTORS | PERIPHERAL VASCULAR DISEASE | HDL-CHOLESTEROL | DYSLIPIDEMIA | PRIMARY PREVENTION | CARDIOVASCULAR RISK-FACTORS | Secondary Prevention - trends | Humans | Middle Aged | Patient Discharge | Coronary Disease - epidemiology | Male | Drug Utilization Review | Young Adult | Dyslipidemias - blood | Time Factors | Guideline Adherence - trends | Lipids - blood | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Dyslipidemias - diagnosis | Coronary Disease - blood | Dyslipidemias - drug therapy | Cross-Sectional Studies | Risk Assessment | Risk Factors | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Coronary Disease - diagnosis | Drug Prescriptions | Practice Patterns, Physicians' - trends | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Coronary Disease - drug therapy | Aged | Healthcare Disparities - trends | Health Care Surveys | Practice Guidelines as Topic | Surveys | Medical research | Blood cholesterol | Cardiac patients | Low density lipoproteins | Mortality | Medicine, Experimental | Cardiovascular agents | Index Medicus
Journal Article
02/2013
Background: Obesity is an independent risk factor of preeclampsia with unknown mechanism and hyperlipidemia might be a probable case of it. Objective: The... 
Dyslipidemia | Pre-eclampsia | Overweight
Web Resource
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, pp. e0153497 - e0153497
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of... 
DIAGNOSIS | AMERICAN ASSOCIATION | RECOMMENDATIONS | MULTIDISCIPLINARY SCIENCES | CONTROLLED ATTENUATION PARAMETER | MARKERS | STEATOHEPATITIS | MICRORNAS | HEPATIC STEATOSIS | EXPRESSION | PCR | Dyslipidemias - genetics | Up-Regulation | Liver - pathology | Cross-Sectional Studies | Dyslipidemias - complications | Non-alcoholic Fatty Liver Disease - genetics | Humans | Middle Aged | Male | Non-alcoholic Fatty Liver Disease - complications | Young Adult | Caenorhabditis elegans | Non-alcoholic Fatty Liver Disease - blood | Dyslipidemias - blood | Animals | Non-alcoholic Fatty Liver Disease - diagnosis | Adult | Female | MicroRNAs - blood | MicroRNAs - genetics | Dyslipidemias - diagnosis | Complications and side effects | MicroRNA | Fatty liver | Dyslipidemias | Physiological aspects | Genetic aspects | Research | Risk factors | Biotechnology | Correlation | Nuclear magnetic resonance--NMR | Transplants & implants | Liver | Dyslipidemia | Feasibility analysis | Liver cancer | Hepatitis | Ultrasonic imaging | Bioindicators | Obesity | Liver diseases | Medical imaging | Feasibility studies | MiRNA | Inflammation | Metabolism | Gene expression | Patients | Low density lipoprotein | Cholesterol | Lipoproteins (very low density) | Steatosis | Serum levels | Cirrhosis | Weight control | Biopsy | MicroRNAs | Fibrosis | Biomarkers | Diagnostic systems | Diabetes | Methods | Index Medicus | Nuclear magnetic resonance | NMR
Journal Article
Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 02/2018, Volume 11, Issue 2, pp. 410 - 412
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2013, Volume 7, Issue 4, pp. 304 - 383
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 2, pp. 129 - 169
Journal Article
Lipids in Health and Disease, ISSN 1476-511X, 09/2018, Volume 17, Issue 1, pp. 208 - 208
Journal Article
Circulation, ISSN 0009-7322, 01/2018, Volume 137, Issue 4, pp. 338 - 350
BACKGROUND:The PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor evolocumab reduced low-density lipoprotein cholesterol and cardiovascular events... 
atherosclerosis | amputation | cholesterol, LDL | evolocumab | peripheral arterial disease | PCSK9 protein, human | intermittent claudication | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | LIMB ISCHEMIA | ATORVASTATIN | STATIN THERAPY | AMPUTATION-FREE SURVIVAL | PERIPHERAL VASCULAR DISEASE | POLYVASCULAR DISEASE | PEOPLE | SIMVASTATIN | ASSOCIATION | Dyslipidemias - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Serine Proteinase Inhibitors - therapeutic use | Dyslipidemias - blood | Time Factors | Serine Proteinase Inhibitors - adverse effects | Amputation | Peripheral Arterial Disease - blood | Cholesterol, LDL - blood | Female | Dyslipidemias - diagnosis | Dyslipidemias - drug therapy | Limb Salvage | Down-Regulation | Risk Factors | Treatment Outcome | Biomarkers - blood | Proprotein Convertase 9 - metabolism | Anticholesteremic Agents - adverse effects | Peripheral Arterial Disease - mortality | Peripheral Arterial Disease - therapy | Anticholesteremic Agents - therapeutic use | Peripheral Arterial Disease - diagnosis | Proprotein Convertase 9 - antagonists & inhibitors | Aged | Cholesterol, LDL | Care and treatment | Research | Peripheral vascular diseases | Cardiovascular diseases | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article